ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Sera Prognostics Inc

Sera Prognostics Inc (SERA)

7.80
-0.10
(-1.27%)
Closed July 22 4:00PM
7.78
-0.02
(-0.26%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
7.80
Bid
1.00
Ask
9.50
Volume
172,018
7.675 Day's Range 8.05
1.52 52 Week Range 12.355
Market Cap
Previous Close
7.90
Open
7.97
Last Trade Time
Financial Volume
$ 1,340,866
VWAP
7.7949
Average Volume (3m)
153,600
Shares Outstanding
32,653,777
Dividend Yield
-
PE Ratio
-7.01
Earnings Per Share (EPS)
-1.11
Revenue
306k
Net Profit
-36.24M

About Sera Prognostics Inc

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications. Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Wilmington, Delaware, USA
Founded
1970
Sera Prognostics Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker SERA. The last closing price for Sera Prognostics was $7.90. Over the last year, Sera Prognostics shares have traded in a share price range of $ 1.52 to $ 12.355.

Sera Prognostics currently has 32,653,777 shares outstanding. The market capitalization of Sera Prognostics is $257.96 million. Sera Prognostics has a price to earnings ratio (PE ratio) of -7.01.

SERA Latest News

Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial

Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial PR Newswire SALT LAKE CITY, July 9, 2024...

SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION

SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION PR Newswire SALT LAKE CITY, July 1, 2024 SALT LAKE CITY, July 1, 2024...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.56256.248.145.9151522967.41884706CS
40.7110.01410437247.098.144.982019936.18768816CS
12-2.48-24.124513618710.2812.3554.981536007.73307844CS
261.8631.31313131315.9412.3554.981896348.3722298CS
524.551403.2512.3551.524852305.94156332CS
156-2.95-27.441860465110.7513.511.13085004.5495945CS
260-7.21-48.03464357115.0115.51.13118154.6448188CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
AUGXAugmedix Inc
$ 2.27
(147.71%)
24.14M
XCURExicure Inc
$ 0.5351
(76.02%)
14.02M
PSNLPersonalis Inc
$ 3.83
(56.33%)
22.8M
MDBHMDB Capital Holdings LLC
$ 10.675
(37.21%)
126.45k
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M
HYZNHyzon Motors Inc
$ 0.149
(-47.54%)
23.63M
MEDSTRxADE Health Inc
$ 14.92
(-33.45%)
223.27k
SILOSilo Pharma Inc
$ 2.50
(-27.95%)
11.93M
KITTNauticus Robotics Inc
$ 0.0935
(-27.46%)
28.43M
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2602
(5.77%)
226.82M
NVDANVIDIA Corporation
$ 117.93
(-2.61%)
217.11M
SQQQProShares UltraPro Short QQQ
$ 8.46
(2.79%)
188.2M
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M

Your Recent History

Delayed Upgrade Clock